Chapter 18: Anti-Ribosomal Antibiotics

The chapter organizes these drugs using the CLEAN TAG mnemonic framework, which categorizes medications based on which ribosomal subunit they target and their mechanism of action. The first major category addresses 50S subunit inhibitors, beginning with chloramphenicol, a broad-spectrum agent whose clinical utility is severely limited by its capacity to cause dose-dependent bone marrow suppression and the potentially fatal Gray Baby Syndrome in newborns, a condition arising from hepatic immaturity and impaired glucuronidation. Clindamycin provides valuable coverage against anaerobic organisms but carries a significant risk of triggering pseudomembranous colitis through Clostridioides difficile overgrowth. The chapter then explores macrolides and related compounds, explaining their effectiveness in treating respiratory infections caused by atypical pathogens such as Legionella, Mycoplasma, and Chlamydia species. Oxazolidinones, particularly linezolid, represent newer alternatives for managing multidrug-resistant infections including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. The discussion then shifts to 30S subunit inhibitors, particularly the tetracycline family, which includes conventional agents like doxycycline and newer representatives such as tigecycline. These medications excel in treating intracellular infections and vector-borne diseases but require careful consideration of adverse effects including photosensitivity reactions, inhibition of skeletal development, and permanent dental discoloration in pediatric patients. Finally, the chapter concludes with aminoglycosides, which demonstrate potent bactericidal activity specifically against aerobic gram-negative bacteria through their mechanism of action on ribosomal translation. Despite their effectiveness, aminoglycosides present serious dose-limiting toxicities, most notably irreversible nephrotoxicity affecting renal function and ototoxicity causing hearing loss and vestibular system dysfunction. Understanding these agents' mechanisms, clinical applications, and toxicity profiles is essential for rational antimicrobial prescribing.